Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ACER | Acer Therapeutics Inc. | TVM Life Science Ventures VI GmbH & Co KG | Director | Dec 12, 2017 | Buy | $12.00 | 333,333 | 3,999,996 | 1,422,709 | Jan 12, 2018, 02:33 PM | |
PRTO | PROTEON THERAPEUTICS INC | TVM Life Science Ventures VI GmbH & Co KG | 10% Owner | Oct 27, 2014 | Buy | $10.00 | 223,410 | 2,234,100 | 223,410 | Oct 30, 2014, 08:23 AM | |
PRTO | PROTEON THERAPEUTICS INC | TVM Life Science Ventures VI GmbH & Co KG | 10% Owner | Oct 27, 2014 | Option Exercise | $4.60 | 116,511 | 536,219 | 1,903,127 | Oct 30, 2014, 08:23 AM | |
PRTO | PROTEON THERAPEUTICS INC | TVM Life Science Ventures VI GmbH & Co KG | 10% Owner | Oct 27, 2014 | Buy | $10.00 | 76,590 | 765,900 | 300,000 | Oct 30, 2014, 08:23 AM | |
PRTO | PROTEON THERAPEUTICS INC | TVM Life Science Ventures VI GmbH & Co KG | 10% Owner | Oct 27, 2014 | Option Exercise | $4.60 | 39,932 | 183,779 | 1,943,059 | Oct 30, 2014, 08:23 AM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | TVM Life Science Ventures VI GmbH & Co KG | Director | Feb 19, 2014 | Buy | $14.00 | 22,713 | 317,982 | 378,703 | Feb 20, 2014, 08:35 AM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | TVM Life Science Ventures VI GmbH & Co KG | Director | Feb 19, 2014 | Buy | $14.00 | 66,287 | 928,018 | 1,104,969 | Feb 20, 2014, 08:35 AM |